Novartis Buys Cancer-Drug Firm Myricx for Up to $1.5 Billion

Novartis to buy RNA-focused Avidity in $12 billion deal

Novartis Agrees to Buy Avidity in $12 Billion Biotech Deal

Alphabet’s Isomorphic Labs to Collaborate With Novartis, Lilly